172 related articles for article (PubMed ID: 17300887)
21. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
22. [Preparation and characterization of solid lipid nanoparticles of norcantharidin].
Tian HY; Zhai GX
Zhong Yao Cai; 2007 Sep; 30(9):1146-8. PubMed ID: 18236763
[TBL] [Abstract][Full Text] [Related]
23. Lipid nanoparticles as vitamin matrix carriers in liquid food systems: On the role of high-pressure homogenisation, droplet size and adsorbed materials.
Shukat R; Relkin P
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):119-24. PubMed ID: 21524892
[TBL] [Abstract][Full Text] [Related]
24. A facile construction strategy of stable lipid nanoparticles for drug delivery using a hydrogel-thickened microemulsion system.
Chen H; Xiao L; Du D; Mou D; Xu H; Yang X
Nanotechnology; 2010 Jan; 21(1):015101. PubMed ID: 19946154
[TBL] [Abstract][Full Text] [Related]
25. UHPH-processed O/W submicron emulsions stabilised with a lipid-based surfactant: physicochemical characteristics and behaviour on in vitro TC7-cell monolayers and ex vivo pig's ear skin.
Benzaria A; Gràcia-Julià A; Picart-Palmade L; Hue P; Chevalier-Lucia D; Marti-Mestres G; Hodor N; Dumay E
Colloids Surf B Biointerfaces; 2014 Apr; 116():237-46. PubMed ID: 24480065
[TBL] [Abstract][Full Text] [Related]
26. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands.
Pedersen N; Hansen S; Heydenreich AV; Kristensen HG; Poulsen HS
Eur J Pharm Biopharm; 2006 Feb; 62(2):155-62. PubMed ID: 16290122
[TBL] [Abstract][Full Text] [Related]
27. Employment of cationic solid-lipid nanoparticles as RNA carriers.
Montana G; Bondì ML; Carrotta R; Picone P; Craparo EF; San Biagio PL; Giammona G; Di Carlo M
Bioconjug Chem; 2007; 18(2):302-8. PubMed ID: 17253655
[TBL] [Abstract][Full Text] [Related]
28. Design and production of nanoparticles formulated from nano-emulsion templates-a review.
Anton N; Benoit JP; Saulnier P
J Control Release; 2008 Jun; 128(3):185-99. PubMed ID: 18374443
[TBL] [Abstract][Full Text] [Related]
29. Parameters with influence on the droplet size of w/o emulsions.
Lindenstruth K; Müller BW
Pharmazie; 2004 Mar; 59(3):187-90. PubMed ID: 15074589
[TBL] [Abstract][Full Text] [Related]
30. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
You J; Wan F; de Cui F; Sun Y; Du YZ; Hu FQ
Int J Pharm; 2007 Oct; 343(1-2):270-6. PubMed ID: 17706383
[TBL] [Abstract][Full Text] [Related]
31. Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion.
Anton N; Gayet P; Benoit JP; Saulnier P
Int J Pharm; 2007 Nov; 344(1-2):44-52. PubMed ID: 17592746
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism, crystallinity and hydrophilic-lipophilic balance of stearic acid and stearic acid-capric/caprylic triglyceride matrices for production of stable nanoparticles.
Severino P; Pinho SC; Souto EB; Santana MH
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):125-30. PubMed ID: 21543196
[TBL] [Abstract][Full Text] [Related]
33. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
34. Preparation of curcumin microemulsions with food-grade soybean oil/lecithin and their cytotoxicity on the HepG2 cell line.
Lin CC; Lin HY; Chi MH; Shen CM; Chen HW; Yang WJ; Lee MH
Food Chem; 2014 Jul; 154():282-90. PubMed ID: 24518344
[TBL] [Abstract][Full Text] [Related]
35. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
36. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil.
Sharma P; Ganta S; Denny WA; Garg S
Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127
[TBL] [Abstract][Full Text] [Related]
37. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
38. Application of microemulsions in dermal and transdermal drug delivery.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Skin Pharmacol Physiol; 2008; 21(5):246-59. PubMed ID: 18562799
[TBL] [Abstract][Full Text] [Related]
39. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
40. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.
Chattopadhyay P; Shekunov BY; Yim D; Cipolla D; Boyd B; Farr S
Adv Drug Deliv Rev; 2007 Jul; 59(6):444-53. PubMed ID: 17582648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
